Sight Sciences Analyst Price Targets - Benzinga

Sight Sciences Inc

SGHTNASDAQ

Trade with Public

Trade with Public

$8.62

0.364.36%

最終更新: Oct 20, 9:30 AM

$8.09

-0.17-2.06%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Sight Sciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Sight Sciences (SGHT).

Price Target Range — 13 Quarters

Analyst Consensus — 7 Analysts

5Buy

2Hold

Consensus RatingBuy# Analysts7Avg. Consensus PT$9Upside to Avg. PT+14.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 15, 2026	HC Wainwright & Co.	Yi Chen	Initiate	Buy	$14
Oct 5, 2026	Citigroup	Joanne Wuensch	PT Raise	Neutral	$8→$10
Aug 17, 2026	Citigroup	Joanne Wuensch	PT Raise	Neutral	$6→$8
Aug 6, 2026	UBS	Patrick Wood	PT Raise	Buy	$7→$8
Jul 28, 2026	UBS	Patrick Wood	Assumes	Buy	$11→$7
Jul 8, 2026	Citigroup	Joanne Wuensch	PT Raise	Neutral	$5→$6
May 28, 2026	Citigroup	Joanne Wuensch	PT Raise	Neutral	$4→$5
Mar 6, 2026	UBS	Danielle Antalffy	PT Cut	Buy	$12→$11
Mar 6, 2026	Citigroup	Joanne Wuensch	PT Cut	Neutral	$9→$7
Mar 2, 2026	Stifel	Thomas Stephan	PT Raise	Buy	$6→$8
Jan 5, 2026	Piper Sandler	Adam Maeder	Upgrade	Neutral→Overweight	$5→$9
Dec 23, 2025	UBS	Danielle Antalffy	PT Raise	Buy	$7→$12
Dec 11, 2025	Citigroup	Joanne Wuensch	PT Raise	Neutral	$6→$9
Dec 10, 2025	Lake Street	Frank Takkinen	PT Raise	Buy	$7→$12
Dec 2, 2025	Morgan Stanley	Cecilia Furlong	PT Raise	Equal-Weight	$6→$8
Nov 10, 2025	Morgan Stanley	Cecilia Furlong	PT Raise	Equal-Weight	$4→$6
Nov 7, 2025	Piper Sandler	Adam Maeder	PT Raise	Neutral	$4→$5
Oct 21, 2025	Lake Street	Frank Takkinen	PT Raise	Buy	$5→$7
Oct 7, 2025	Citigroup	Joanne Wuensch	PT Cut	Neutral	$5→$4
Aug 28, 2025	Needham	David Saxon	Maintained	Hold	—

More with Benzinga EdgeGet Access

Analyst Ratings News

Why Is Sight Sciences Stock Gaining Thursday?

Sight Sciences (SGHT) stock jumped after H.C. Wainwright initiated coverage with a Buy rating and a $14 price target — nearly 70% upside.

Vandana Singh

This Eloxx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiated coverage: Neutral on RDW, Overweight on ELOX, Buys on SGHT and AU, and Market Perform on FFIN.

Avi Kapoor

PRO
HC Wainwright & Co. Initiates Coverage On Sight Sciences with Buy Rating, Announces Price Target of $14

HC Wainwright & Co. analyst Yi Chen initiates coverage on Sight Sciences (NASDAQ:SGHT) with a Buy rating and announces Price Target of $14.

Benzinga Newsdesk

PRO
UBS Maintains Buy on Sight Sciences, Raises Price Target to $8

UBS analyst Patrick Wood maintains Sight Sciences (NASDAQ:SGHT) with a Buy and raises the price target from $7 to $8.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Sight Sciences, Raises Price Target to $6

Citigroup analyst Joanne Wuensch maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target from $5.15 to $6.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Sight Sciences, Raises Price Target to $5.15

Citigroup analyst Joanne Wuensch maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target from $4.35 to $5.15.

Benzinga Newsdesk